ANTT, ANYWHERE.

Novel packaging technology for single-use devices.

Transforming medical packaging from a passive storage envelope into a standalone, active procedural infection-control system.

DMED product illustration

Physician-led

Developed by a pulmonologist.

US Patent

Granted August 2025.

International IP Coverage

Across 10+ jurisdictions.

Platform IP

Across multiple device categories and industries.

DMED advances procedural infection control

Conventional packaging only protects devices during storage. DMED technology was developed to expand access to ANTT and protect the device throughout the procedure.

Procedural infection-control factor

Conventional Packaging

Function

Passive storage envelope before procedure

Removal

Fully removed

Device exposure

Fully exposed

Key part indication

NO

Contamination risk

High risk once device is fully exposed

Auxiliary equipment and resources

Required

Clinical training

Required

Planning and preparation time

Required

Controlled preparation space

Required

DMED Procedural Barrier Technology

Active infection-control system throughout procedure

Remains around device. Removed in sections at critical moment of use

Only the required part is exposed

YES

Reduced exposure supports reduced contamination risk

Reduced reliance

Reduced reliance

Reduced reliance

Reduced reliance